| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268425A2 Carbamate caspase inhibitors and uses thereof |
| 01/02/2003 | EP1268423A1 Indole derivatives as mcp-1 receptor antagonists |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268413A2 Substituted biphenyl derivatives |
| 01/02/2003 | EP1268407A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1267931A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267910A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267907A1 Use of mia in immunotherapy |
| 01/02/2003 | EP1267905A2 Composition for the treatment of heart failure |
| 01/02/2003 | EP1267882A2 Apoptosis inhibitor with prostaglandin structure |
| 01/02/2003 | EP1267874A2 Therapeutic uses of ppar mediators |
| 01/02/2003 | EP1267857A1 Method of inhibiting the expression of inflammatory cytokines and chemokines |
| 01/02/2003 | EP1267843A1 System for transporting active substances in a biological system |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267833A1 Pharmaceutical preparations and their manufacture |
| 01/02/2003 | EP1267832A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267831A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267828A2 Pharmaceutical preparations |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267798A1 Treatment of skin damage using polyenylphosphatidylcholine |
| 01/02/2003 | EP1267760A2 Medical procedure |
| 01/02/2003 | EP1115716B1 2-phenylpyran-4-one derivatives |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 01/02/2003 | EP0863754B1 Hydrolysis-optimized lipid emulsions and use thereof |
| 01/02/2003 | EP0828727B1 Cyclohexyl dihydrobenzofuranes |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/01/2003 | CN1388759A Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use |
| 01/01/2003 | CN1387900A Medicine ointment for eliminating pain of bones and muscles |
| 01/01/2003 | CN1387898A Medicine for treating rheumatism and rheumatoid disease |
| 01/01/2003 | CN1387897A Wind-fire toothache powder and its prepn |
| 01/01/2003 | CN1387885A Chinese medicine wine for treating rheumatism and arthralgia |
| 01/01/2003 | CN1387883A Chinese medicine extract and its application |
| 01/01/2003 | CN1387877A Tonic wine for resisting rheumatism and rhematoid diseases |
| 01/01/2003 | CN1387847A Lefunomide plaster and its prepn |
| 01/01/2003 | CN1387842A Transdermal plaster of aryl propionic non-steroid antiphlogistic |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 01/01/2003 | CN1097459C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 12/31/2002 | US6500923 Isolated polypeptide that binds to an autoantibody from a dermatomyositis patient to provide means by which dermatomyositis can be detected by way of differential diagnosis |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500839 CRF receptor antagonists and methods relating thereto |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500418 Stimulating neutrophil function to treat inflammatory bowel disease |
| 12/31/2002 | CA2227814C Substituted benzylaminopiperidine compounds |
| 12/31/2002 | CA2097732C Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/30/2002 | WO2002002582A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/30/2002 | CA2414605A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002102800A1 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 12/27/2002 | WO2002102794A2 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102778A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | WO2002102775A1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 12/27/2002 | WO2002102770A1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 12/27/2002 | WO2002102768A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 12/27/2002 | WO2002102757A1 Glycerol-peg-derivatives as inhibitors of cyclooxygenase-2 and phospholipase-a2 |
| 12/27/2002 | WO2002102396A1 Preventives or remedies for arthritis |
| 12/27/2002 | WO2002102383A1 Aqueous cilostazol preparation for injection |
| 12/27/2002 | WO2002102379A1 Sophoridine and use thereof as an analgesic |
| 12/27/2002 | WO2002102376A1 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT |
| 12/27/2002 | WO2002102365A1 Tricyclic terpenes of the family of abietic acid as rantes receptor ligands |
| 12/27/2002 | WO2002102364A1 Pparg agonistic medicinal compositions |
| 12/27/2002 | WO2002102344A2 No-synthase inhibitor and use thereof |
| 12/27/2002 | WO2002102343A1 Ascorbyl 2-hexadecanoate as a no-synthase inhibitor |
| 12/27/2002 | WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002102304A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
| 12/27/2002 | WO2002083696A3 Novel cyclo azaphospha hydrocarbons |
| 12/27/2002 | WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. |
| 12/27/2002 | WO2002072077A3 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | WO2002060922A3 Epoxyvibsanin b |
| 12/27/2002 | WO2002056907A3 Molecular antigen array presenting amyloid beta |
| 12/27/2002 | WO2002056888A3 Assay method, tnf modulator and its use |
| 12/27/2002 | WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 12/27/2002 | WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 12/27/2002 | WO2002000877A3 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |